Dare Bioscience Files 8-K for Unspecified Event
Ticker: DARE · Form: 8-K · Filed: Jul 21, 2025 · CIK: 1401914
Sentiment: neutral
Topics: 8-k, other-event
TL;DR
Dare Bioscience filed an 8-K on 7/18 for an 'Other Event' - details to follow.
AI Summary
On July 18, 2025, Dare Bioscience, Inc. filed an 8-K report detailing an 'Other Event'. The filing does not provide specific details about the event itself, but it was submitted to the SEC on July 21, 2025. The company, previously known as Cerulean Pharma Inc. and Tempo Pharmaceuticals Inc., is incorporated in Delaware and headquartered in San Diego, California.
Why It Matters
This 8-K filing indicates a significant event has occurred for Dare Bioscience, Inc., requiring immediate disclosure to the public and investors.
Risk Assessment
Risk Level: medium — The filing is an 8-K for an 'Other Event' without immediate detail, suggesting a potentially material development that investors need to monitor.
Key Numbers
- 001-36395 — SEC File Number (Identifies the company's filing history with the SEC.)
- 20-4139823 — EIN (Employer Identification Number for Dare Bioscience, Inc.)
Key Players & Entities
- Dare Bioscience, Inc. (company) — Registrant
- Cerulean Pharma Inc. (company) — Former company name
- Tempo Pharmaceuticals Inc (company) — Former company name
- July 18, 2025 (date) — Date of earliest event reported
- July 21, 2025 (date) — Filing date
- 3655 Nobel Drive, Suite 260, San Diego, CA 92122 (location) — Principal Executive Offices
FAQ
What specific event prompted this 8-K filing?
The filing is categorized under 'Other Events' and does not specify the exact nature of the event in the provided text.
When was the earliest event reported in this filing?
The earliest event reported was on July 18, 2025.
When was this 8-K report filed with the SEC?
The report was filed as of date July 21, 2025.
What were Dare Bioscience, Inc.'s former company names?
Dare Bioscience, Inc. was formerly known as Cerulean Pharma Inc. and Tempo Pharmaceuticals Inc.
Where are Dare Bioscience, Inc.'s principal executive offices located?
The principal executive offices are located at 3655 Nobel Drive, Suite 260, San Diego, CA 92122.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on July 21, 2025 regarding Dare Bioscience, Inc. (DARE).